Skip to main content


  • Sunday, Jan 21st
    10:30 AM – 11:30 AM MT
    Deadly Fungus: Not the Last of Us Yet
    Location: North-120A
    Concurrent Session Moderator: Henry Masur, MD, FCCM – George Washington University School of Medicine
    Infection
     CE: 1.0 ACE Credits
  • Sunday, Jan 21st
    10:35 AM – 10:50 AM MT
    Epidemiology of Fungal Disease in the Critically Ill
    Location: North-120A
    Concurrent Session Faculty: Talia K. Ben-Jacob, MD, MSc, FCCM – n/a
    Infection
  • Sunday, Jan 21st
    10:50 AM – 11:05 AM MT
    Fungus Among Us: New Diagnostic Methods and Identification of Fungal Disease
    Location: North-120A
    Concurrent Session Faculty: Daniel Sweeney, MD – University of California San Diego
    Infection
  • Sunday, Jan 21st
    11:05 AM – 11:20 AM MT
    Something Old, Something New, Should We Just Go to Isavu?
    Location: North-120A
    Concurrent Session Faculty: John M. Allen, PharmD, BCPS, BCCCP, (he/him/his) – University of Florida College of Pharmacy
    Infection
  • Sunday, Jan 21st
    11:45 AM – 1:15 PM MT
    Clinical Evidence for Host-Directed Therapeutics
    Location: North-120A
    Infection
     CE: 1.5 ACE Credits
  • Sunday, Jan 21st
    11:50 AM – 12:00 PM MT
    Repurposing Host-Directed Therapeutics for COVID-19
    Location: North-120A
    P Speaker: Larry Tsai – Genentech, Inc.
    Infection
  • Sunday, Jan 21st
    12:00 PM – 12:10 PM MT
    The Role of Platform Trials
    Location: North-120A
    P Speaker: Qun Wu, MD, PhD, (she/her/hers) – HHS/ASPR/BARDA/IEIDD
    Infection
  • Sunday, Jan 21st
    12:10 PM – 12:20 PM MT
    The Use of Clinical Data to Inform and Identify the Potential New Value of Existing HDTs
    Location: North-120A
    P Speaker: Heather Stone, MPH (she/her/hers) – US Food & Drug Administration
    Infection
  • Sunday, Jan 21st
    12:20 PM – 12:30 PM MT
    Clinical Evidence Necessary to Support Clinical Guidelines for the Use of HDTs
    Location: North-120A
    P Speaker: Steven Q. Simpson, MD – The University of Kansas Health System
    Infection
  • Sunday, Jan 21st
    12:30 PM – 12:40 PM MT
    Clinical Unmet Need for HDTs
    Location: North-120A
    P Speaker: Craig Coopersmith, MD, MCCM – Emory University Hospital
    Infection
  • Sunday, Jan 21st
    12:40 PM – 12:50 PM MT
    BARDA’s Interest in HDTs and Funding Opportunities
    Location: North-120A
    Infection
  • Sunday, Jan 21st
    12:50 PM – 1:15 PM MT
    Panel Discussion
    Location: North-120A
    Infection
  • Monday, Jan 22nd
    3:15 PM – 4:15 PM MT
    The Power of the Microbiome: Its Role in the Development, Maintenance, and Outcomes of Sepsis
    Location: West-301BC
    Concurrent Session Moderator: Ryan Maves, MD, FCCM – Wake Forest University School of Medicine
    Infection
     CE: 1.0 ACE Credits
  • Monday, Jan 22nd
    3:20 PM – 3:35 PM MT
    Microbiome and Critical Illness: Impacts on Human Health
    Location: West-301BC
    Concurrent Session Faculty: Juliane Bubeck-Wardenburg, MD, PhD – Washington University in Saint Louis School of Medicine
    Infection
  • Monday, Jan 22nd
    3:35 PM – 3:50 PM MT
    A Fad or a Competent Therapy: Sepsis and the Microbiome
    Location: West-301BC
    Concurrent Session Faculty: Paul Wischmeyer, MD, EDIC, FASPEN – Duke University School of Medicine
    Infection
  • Monday, Jan 22nd
    3:50 PM – 4:05 PM MT
    Inflammation and the Microbiome: Age-Related Outcomes in the Geriatric Septic Patient
    Location: West-301BC
    Concurrent Session Faculty: Vidula Vachharajani, MD, FCCP, FCCM (she/her/hers) – Cleveland Clinic Lerner College of Medicine
    Infection